alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 13.1
 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
   1.
    
    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange
Act; and2.
    
    the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of JX Holdings, Inc.
  By:

/s/ Shinji NishioName:
    Shinji NishioTitle:
    Chairman of the Board
(Co-principal executive officer)By:

/s/
Mitsunori TakahagiName:
    Mitsunori TakahagiTitle:
    President
(Co-principal executive officer)By:
    /s/ Shigeo HiraiName:
    Shigeo HiraiTitle:
    Executive Vice President
(Co-principal financial officer)By:

/s/ Kiyonobu SugiuchiName:
    Kiyonobu SugiuchiTitle:
    Senior Vice President
(Co-principal financial officer) 13.1-1
### NUMBER 13

- 10

- 00508

- C V

COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI

- EDINBURG

IN RE : KIRK WAYNE M c BRIDE, SR.

On Petition for Writ of Mandamus.



## MEMORANDUM OPINION

Before Justices Yañez, Garza, and Benavides Memorandum Opinion Per Curiam

Relator, Kirk Wayne McBride, Sr., pro se, filed a petition for writ of mandamus in

th e above cause on September 17, 2010 , seeking to compel the trial court to rule on a

“Petition for Temporary Restraining Order.” According to the petition, relator submitted

his request for a temporary restraining order to the district clerk on July 14, 2010,

however, the trial court has not yet issued a ruling thereon. We deny the petition for writ

of mandamus.

First, the petition for writ of mandamus fails to comply with the Texas Rules of

Appellate Procedure. See generally T EX

. R. A PP

. P . 52.3. Second, relator has notdemonstrated either that the trial court expressly refused to rule on relator’s petition for

temporary restraining order or that an unreasonable amount of time has passed since

the petition was filed. See In re Dimas , 88 S.W.3d 349, 351 (Tex. App.

– San Antonio

2002, orig. proceeding); In re Chavez , 62 S.W.3d 225, 228 (Tex. App.

– Amarillo 2001,

orig. proceeding); Barnes v. State , 832 S.W.2d 424, 426 (Tex. App.

– Houston [1st Dist.]

1992, orig. proceeding); accord O'Connor v. First Ct. of Appeals , 837 S.W.2d 94, 97

(Tex. 1992) (orig. proceeding).

The Court, having examined and fully considered the petition for writ of

m andamus , is of the opinion that relator has not shown himself entitled to the relief

sought. Accordingly, the petition for writ of mandamus is DENIED. See T EX

. R. A PP

. P

.

52.8 (a).

PER CURIAM

D elivered and filed the 8th day of October , 2010.
Joseph A. WILSON, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-1667

District Court of Appeal of Florida, Second District.

Opinion filed September 29, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<TABLE> <S> <C>

<ARTICLE>                                               9
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                               Dec-31-1999
<PERIOD-END>                                    Mar-31-1999
<CASH>                                            3,942,875
<INT-BEARING-DEPOSITS>                              128,827
<FED-FUNDS-SOLD>                                    300,000
<TRADING-ASSETS>                                          0
<INVESTMENTS-HELD-FOR-SALE>                      61,462,989
<INVESTMENTS-CARRYING>                           10,079,987
<INVESTMENTS-MARKET>                             71,738,439
<LOANS>                                         129,759,813
<ALLOWANCE>                                       2,175,171
<TOTAL-ASSETS>                                  214,831,834
<DEPOSITS>                                      185,312,338
<SHORT-TERM>                                      2,402,166
<LIABILITIES-OTHER>                               1,358,398
<LONG-TERM>                                       8,000,000
<PREFERRED-MANDATORY>                                     0
<PREFERRED>                                               0
<COMMON>                                          2,239,775
<OTHER-SE>                                       15,341,563
<TOTAL-LIABILITIES-AND-EQUITY>                  214,831,834
<INTEREST-LOAN>                                   2,717,413
<INTEREST-INVEST>                                 1,075,382
<INTEREST-OTHER>                                        562
<INTEREST-TOTAL>                                  3,793,397
<INTEREST-DEPOSIT>                                  883,948
<INTEREST-EXPENSE>                                1,016,436
<INTEREST-INCOME-NET>                             2,776,961
<LOAN-LOSSES>                                        90,000
<SECURITIES-GAINS>                                        0
<EXPENSE-OTHER>                                   1,883,595
<INCOME-PRETAX>                                   1,619,866
<INCOME-PRE-EXTRAORDINARY>                        1,033,109
<EXTRAORDINARY>                                           0
<CHANGES>                                                 0
<NET-INCOME>                                      1,033,109
<EPS-PRIMARY>                                          1.26
<EPS-DILUTED>                                          1.26
<YIELD-ACTUAL>                                         7.93
<LOANS-NON>                                       1,547,565
<LOANS-PAST>                                              0
<LOANS-TROUBLED>                                          0
<LOANS-PROBLEM>                                           0
<ALLOWANCE-OPEN>                                  2,120,371
<CHARGE-OFFS>                                        64,556
<RECOVERIES>                                         29,356
<ALLOWANCE-CLOSE>                                 2,175,171
<ALLOWANCE-DOMESTIC>                              2,175,171
<ALLOWANCE-FOREIGN>                                       0
<ALLOWANCE-UNALLOCATED>                             762,557
        

</TABLE>
Jerry D. PAIGE, Appellant, v. STATE of Florida, Appellee.

CASE NO. 1D17-3198

District Court of Appeal of Florida, First District.

Opinion filed October 17, 2017 Rehearing Denied December 29, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
# Službeni list C 447I/2020

| | ISSN 1977-1088 |
| --- | --- |
| Službeni list
  Europske unije | C 447I |
| | |
| Hrvatsko izdanje | Informacije i objave | Godište 63.24. prosinca 2020. |

ISSN 1977-1088

Službeni list

Europske unije

C 447I

Hrvatsko izdanje

Informacije i objave

Godište 63.24. prosinca 2020.

---

| Sadržaj | Stranica |
| --- | --- |
| | IV.   Obavijesti |
| | OBAVIJESTI INSTITUCIJA, TIJELA, UREDA I AGENCIJA EUROPSKE UNIJE |
| | Europska komisija |
| 2020/C 447 I/01 | Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 21 December 2020 do 21 December 2020( SL C 136, 30.4.2004. ) | 1 |

Sadržaj

Stranica

IV.   Obavijesti

OBAVIJESTI INSTITUCIJA, TIJELA, UREDA I AGENCIJA EUROPSKE UNIJE

Europska komisija

2020/C 447 I/01

Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 21 December 2020 do 21 December 2020( SL C 136, 30.4.2004. )

( SL C 136, 30.4.2004. )

1

---

| HR | |
| --- | --- |

HR

---

IV. Obavijesti

OBAVIJESTI INSTITUCIJA, TIJELA, UREDA I AGENCIJA EUROPSKE UNIJE

Europska komisija

| 24.12.2020 | HR | Službeni list Europske unije | CI 447/1 |
| --- | --- | --- | --- |

24.12.2020

HR

Službeni list Europske unije

CI 447/1

---

Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 21 December 2020 do 21 December 2020

(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća (1))

(2020/C 447 I/01)

| — | Izdavanje odobrenja za stavljanje u promet (članak 13 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno |
| --- | --- |

—

Izdavanje odobrenja za stavljanje u promet (članak 13 Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

| Datum odluke | Naziv lijeka | INN (medunarodni nezašticeni naziv lijeka) | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Farmaceutski oblik | Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova) | Datum obavijesti |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 21.12.2020 | Comirnaty | mRNA cjepivo protiv bolesti COVID-19 (s modificiranim nukleozidom) | BioNTech Manufacturing GmbH An der Goldgrube 12, 55131 Mainz, Deutschland | EU/1/20/1528 | Koncentrat za disperziju za injekciju | J07BX | 21.12.2020 |

Datum odluke

Naziv lijeka

INN (medunarodni nezašticeni naziv lijeka)

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Farmaceutski oblik

Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

Datum obavijesti

21.12.2020

Comirnaty

mRNA cjepivo protiv bolesti COVID-19 (s modificiranim nukleozidom)

BioNTech Manufacturing GmbH An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

Koncentrat za disperziju za injekciju

J07BX

21.12.2020

Zainteresirane osobe koje žele na uvid dobiti javno izvješće o procjeni predmetnih lijekova i odluka koje se na njih odnose trebale bi se obratiti:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NETHERLANDS |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

---

(1)  SL L 136, 30.4.2004, str. 1.

---
Exhibit 99.4 - Chief Financial Officer Certification (Section 906)

                            CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of PaperFree Medical Solutions, Inc.
(the "Company") on Form 10-QSB for the period ending May 31, 2005 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"). I,
William L Sklar, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge and belief:

               (1)   The Report fully complies with the requirements of
                     section 13(a) or 15(d) of the Securities Exchange Act
                     of 1934; and

               (2)   The information contained in the Report fairly presents,
                     in all material respects, the financial condition and
                     result of operations of the Company.

/s/ William L Sklar
---------------------------
    William L Sklar
    Chief Financial Officer


Date  July 20, 2005

<PAGE>
1 

### Nesky, Anthony

To: Nesky, Anthony

Subject: FW: Requesting a public hearing

From: Sweeney, Katie [ mailto:KSweeney@nma.org ]

Sent: Monday, January 26, 2015 10:18 AM

To: Rosencrantz, Ingrid

Subject: Requesting a public hearing

I would like to request that EPA hold a public hearing on its proposed rule, “Health and Environmental Protection

Standards for Uranium and Thorium Mill Tailings.” 80 Fed. Reg. 4156 (Jan. 26, 2015). Please let me know if I need to

make a more formal request or if this email will suffice. I appreciate your assistance.

Katie

Katie Sweeney

Senior Vice President, Legal Affairs & General Counsel

National Mining Association

101 Constitution Avenue, NW

Suite 500 East

Washington, DC 20001

(202) 463-2627

ksweeney@nma.org
STATE of Florida, DEPARTMENT OF HEALTH, Petitioner, v. BAYFRONT HMA MEDICAL CENTER, LLC d/b/a Bayfront Health-St. Petersburg, and Galencare, Inc. d/b/a Northside Hospital, Respondents.

No. 1D17-2200

District Court of Appeal of Florida, First District.

January 2, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
** EXHIBIT 3.1**

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

 

|   |
|--------|
|        |
|        |
|   |

 

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
|   |
|        |
|   |

 

 

|   |
|--------|
[Federal Register Volume 74, Number 62 (Thursday, April 2, 2009)]
[Notices]
[Page 15062]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7336]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Open Meeting of the Taxpayer Advocacy Panel Volunteer Income Tax 
Assistance Issue Committee

AGENCY: Internal Revenue Service (IRS) Treasury.

ACTION: Corrected Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: An open meeting of the Taxpayer Advocacy Panel Volunteer 
Income Tax Assistance Issue Committee will be conducted. The Taxpayer 
Advocacy Panel is soliciting public comments, ideas and suggestions on 
improving customer service at the Internal Revenue Service.

DATES: The meeting will be Friday, May 8, 2009 and Saturday, May 9, 
2009.

FOR FURTHER INFORMATION CONTACT: Marisa Knispel at 1-888-912-1227 or 
718 488-3557.

SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to Section 
10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) 
that an open meeting of the Taxpayer Advocacy Panel Volunteer Income 
Tax Assistance Issue Committee will be held Friday, May 8, 2009 from 
8:30 a.m. to 4:30 p.m. and Saturday, May 9, 2009 from 8:30 a.m. to 12 
p.m. Eastern Time in Atlanta, GA. The public is invited to make oral 
comments or submit written statements for consideration. Due to limited 
conference lines, notification of intent to participate must be made 
with Marisa Knispel. For more information please contact Ms. Knispel at 
1-888-912-1227 or 718 488-3557, or write TAP Office, 10 MetroTech 
Center, 625 Fulton Street, Brooklyn, NY 11201, or contact us at the Web 
site: http://www.improveirs.org.
    The agenda will include various IRS issues.

    Dated: March 24, 2009.
Shawn F. Collins,
Acting Director, Taxpayer Advocacy Panel.
 [FR Doc. E9-7336 Filed 4-1-09; 8:45 am]
BILLING CODE 4830-01-P
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 877 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
H. RES. 877

     Condemning Mayor Muriel Bowser, Council Chair Phil Mendelson, 
Councilman Charles Allen, and the rest of the government of the city of 
 Washington, DC, for their failure to stop the crime epidemic plaguing 
                              their city.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           November 17, 2023

   Mr. Collins (for himself, Mr. Norman, Mr. Stauber, Mrs. Miller of 
Illinois, Mr. Duncan, Mr. Weber of Texas, Mr. Babin, Mr. LaMalfa, Mrs. 
Bice, and Mr. Arrington) submitted the following resolution; which was 
       referred to the Committee on Oversight and Accountability

_______________________________________________________________________

                               RESOLUTION

 
     Condemning Mayor Muriel Bowser, Council Chair Phil Mendelson, 
Councilman Charles Allen, and the rest of the government of the city of 
 Washington, DC, for their failure to stop the crime epidemic plaguing 
                              their city.

Whereas the policies of Mayor Bowser and the government of the city of 
        Washington, DC (DC government), have made the citizens of Washington, 
        DC, less safe;
Whereas this past year, Members of the House have seen colleagues attacked in 
        elevators and carjacked by armed gunmen;
Whereas Members have witnessed many of their own staff members attacked or 
        harassed this past year;
Whereas the policies of Mayor Bowser, Council Chair Phil Mendelson, Councilman 
        Charles Allen, and the DC government are anti-police, anti-citizen, and 
        pro-criminal;
Whereas Councilman Allen is the author of the Revised Criminal Code Act of 2022, 
        which reduced mandatory minimum sentences for carjacking;
Whereas Council Chair Mendelson and Councilman Allen have led the charge for 
        anti-police policies enacted in Washington, DC;
Whereas Washington, DC, has already seen a record number of homicides and 
        violent crime is up compared to last year;
Whereas robberies in Washington, DC, are up compared to last year;
Whereas motor vehicle thefts are up and total property crimes are up compared to 
        last year;
Whereas the Chief of the Metropolitan Police Department recently said that the 
        Department is down approximately 500 officers; and
Whereas it is clear that the anti-police policies of the DC government have led 
        to rising crime, declining enrollment in the police force, and a less 
        safe city: Now, therefore, be it
    Resolved, That the House of Representatives condemns the actions of 
Mayor Muriel Bowser, Council Chair Phil Mendelson, Councilman Charles 
Allen, and the rest of the government of Washington, DC, for their 
failure to stop the crime epidemic plaguing their city.
                                 <all>
```
Unsecured Promissory Note



 Exhibit 10.198 
 UNSECURED PROMISSORY NOTE 
 $100,000.00 Dated: September 11, 2007 
 FOR VALUE RECEIVED, Biovest International, Inc., a Delaware corporation (“Borrower”) promises to pay to the order of Francis E.
O’Donnell, Jr., M.D. (“Lender”), the principal sum of One Hundred Thousand Dollars ($100,000.00). This Unsecured Promissory Note is created on account of the loan by Lender in the sum of $100,000 to pay and satisfy certain
indebtedness of Borrower. 
 INTEREST: The unpaid principal shall bear simple interest at the rate equal to the Prime Rate plus 2% as
published on the last day of each month in the Wall Street Journal. No payment of interest shall be due until maturity. 
 MATURITY:
The entire principal balance of this Note shall be due and payable in full on the earlier of (i) The date of closing of a sale of non-strategic assets of Borrower resulting in net proceeds of $5 million or more; or (ii) One year from
the date of this Note. There shall be no penalty for early repayment of all or any part of the principal. 
 DEFAULT: The Borrower
shall be in Default of this Note on the occurrence of any of the following events: (i) the Borrower shall fail to meet its obligation to make the required principal or interest payments hereunder; (ii) the Borrower shall be dissolved or
liquidated; (iii) the Borrower shall make an assignment for the benefit of creditors or shall be unable to, or shall admit in writing their inability to pay their debts as they become due; (iv) the Borrower shall commence any case,
proceeding, or other action under any existing or future law of any jurisdiction relating to bankruptcy, insolvency, reorganization or relief of debtors, or any such action shall be commenced against the undersigned; (v) the Borrower shall
suffer a receiver to be appointed for it or for any of its property or shall suffer a garnishment, attachment, levy or execution. 
 REMEDIES: Upon default of this Note, Lender may declare the entire amount due and owing hereunder to be immediately due and payable. Lender may also use all remedies in law and in equity to enforce and collect the amount owed under
this Note. 
 MISCELLANEOUS: Notwithstanding any provision herein or in any documents or instrument now or hereafter securing this
Note, the total liability for payments in the nature of interest shall not exceed the limits now or at any time in the future imposed by the applicable laws of the State of Delaware. 
 This Note shall be governed by, and construed in accordance with, the laws of the State of Delaware, notwithstanding the application of choice of law principles. Borrower hereby waives demand,
presentment, notice of dishonor, diligence in collecting, grace and notice of protest. 
  

			
	 BORROWER:

	 BIOVEST INTERNATIONAL, INC.

		
	 By:
	 	 /s/Steven Arikian

		
	 Name:
	 	 Steven Arikian, M.D.

		
	 Title:
	 	 Chairman & CEO
<TABLE> <S> <C>


<ARTICLE>                     5


<S>                             <C>
<PERIOD-TYPE>                                            3-MOS
<FISCAL-YEAR-END>                                  APR-30-2001
<PERIOD-START>                                     AUG-01-2000
<PERIOD-END>                                       OCT-31-2000
<CASH>                                                 103,000
<SECURITIES>                                                 0
<RECEIVABLES>                                          121,000
<ALLOWANCES>                                                 0
<INVENTORY>                                          1,279,000
<CURRENT-ASSETS>                                     1,400,000
<PP&E>                                               1,754,000
<DEPRECIATION>                                       1,159,000
<TOTAL-ASSETS>                                       2,232,000
<CURRENT-LIABILITIES>                                1,472,000
<BONDS>                                                      0
<PREFERRED-MANDATORY>                                5,608,000
<PREFERRED>                                                  0
<COMMON>                                               233,000
<OTHER-SE>                                          (7,605,000)
<TOTAL-LIABILITY-AND-EQUITY>                         2,232,000
<SALES>                                                805,000
<TOTAL-REVENUES>                                       805,000
<CGS>                                                  113,000
<TOTAL-COSTS>                                        1,380,000
<OTHER-EXPENSES>                                             0
<LOSS-PROVISION>                                             0
<INTEREST-EXPENSE>                                     137,000
<INCOME-PRETAX>                                       (751,000)
<INCOME-TAX>                                                 0
<INCOME-CONTINUING>                                   (751,000)
<DISCONTINUED>                                               0
<EXTRAORDINARY>                                              0
<CHANGES>                                                    0
<NET-INCOME>                                                 0
<EPS-BASIC>                                           (751,000)
<EPS-DILUTED>                                            (0.05)



</TABLE>
R & F DEVELOPERS, LLC, Appellant, v. CENTRO INTERNACIONAL SION, ASAMBLEAS DE DIOS, INC., Appellee.

No. 3D16-1320

District Court of Appeal of Florida, Third District.

Opinion filed November 15, 2017.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.